Genentech inspires the future

As a family physician, you have witnessed first-hand both the challenges and opportunities in the healthcare industry. At Genentech, a member of the Roche Group, they are committed to the overall health and well-being of your patients.

For more than 45 years, Genentech has delivered results in the biotechnology industry. Their groundbreaking discoveries have provided them the opportunity to further their research and development for unmet medical needs.

Currently, Genentech Research and Early Development pipeline has more than 20 new molecular entities in clinical development, including novel therapies for COPD, Asthma and Food Allergy. While this research is costly, Genentech is committed to implementing solutions to lower costs for patients and the healthcare system, all while sustaining their large investments that are necessary for medical breakthroughs.

Through the work of the Genentech Patient Foundation, they express a shared common goal with the AAFP Foundation in bettering the lives of people in need. In the last year alone, Genentech Patient Foundation provided free medicine to more than 60,000 eligible patients.

Genentech has been a member of the AAFP Foundation Partner Program since 2019. Company leaders say they are “proud to partner with the AAFP Foundation to work towards our combined goal of improving the health of all people through the comprehensive management of patient care.”

We thank Genentech for its generous contributions and are grateful for all the corporate partners who support the Foundation’s work to improve the health of people and communities. We invite potential partners to learn more about the AAFP Foundation Partner Program and take the first step toward connecting with the family medicine community in new and meaningful ways.